Interestingly, in this respect, high Siglec-10 levels in hepatocellular cancer patients correlated with significantly higher expression of inhibitory receptor genes such as PD1, TIM3, CTLA-4, or LAG-3 in a more recent study [51]. This evidence concerns the gene HAVCR2 and hepatocellular carcinoma.